122 related articles for article (PubMed ID: 3967090)
1. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
Wolf M; Boyer C; Tripodi A; Meyer D; Larrieu MJ; Mannucci PM
Blood; 1985 Feb; 65(2):496-500. PubMed ID: 3967090
[TBL] [Abstract][Full Text] [Related]
2. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
[TBL] [Abstract][Full Text] [Related]
3. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
5. Homozygous variant of antithrombin III: AT III Fontainebleau.
Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
[TBL] [Abstract][Full Text] [Related]
6. A new familial variant of antithrombin III: 'antithrombin III Paris'.
Wolf M; Boyer C; Lavergne JM; Larrieu MJ
Br J Haematol; 1982 Jun; 51(2):285-95. PubMed ID: 7082587
[TBL] [Abstract][Full Text] [Related]
7. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.
Aiach M; Nora M; Fiessinger JN; Roncato M; François D; Gelas MA
Thromb Res; 1985 Sep; 39(5):559-70. PubMed ID: 4082101
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Tripodi A; Krachmalnicoff A; Mannucci PM
Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
Koide T; Takahashi K; Odani S; Ono T; Sakuragawa N
Thromb Res; 1983 Jul; 31(2):319-28. PubMed ID: 6636046
[TBL] [Abstract][Full Text] [Related]
10. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN
Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.
Sakuragawa N; Takahashi K; Kondo S; Koide T
Thromb Res; 1983 Jul; 31(2):305-17. PubMed ID: 6636045
[TBL] [Abstract][Full Text] [Related]
13. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin Milano, single amino acid substitution at the reactive site, Arg393 to Cys.
Erdjument H; Lane DA; Ireland H; Di Marzo V; Panico M; Morris HR; Tripodi A; Mannucci PM
Thromb Haemost; 1988 Dec; 60(3):471-5. PubMed ID: 3238650
[TBL] [Abstract][Full Text] [Related]
17. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of the "classical" antithrombin III deficiency.
Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
[TBL] [Abstract][Full Text] [Related]
19. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
